Half-Year Report: Revenue and earnings of the Carl Zeiss Group in the first six months of fiscal year 2011/12 remained at approximately the same level as in the prior year.
Revenue reached EUR 2.105 billion, and earnings (EBIT) totaled EUR 232 million. The Broad portfolio largely compensates for cyclical fluctuations in Semiconductor Manufacturing Technology group. Major investments were made in modernization of the company. Investments in research and development increased by 10 percent.
The Industrial Metrology and Medical Technology business groups posted a substantial increase in revenue over fiscal year 2010/11. The revenues of the Microscopy and Vision Care business groups attained the same level as in the previous year. As expected after the record figures achieved in the prior year, the Semiconductor Manufacturing Technology group reported a downturn in revenue which is typical of the business cycles in this sector.
Statement of Dr. Michael Kaschke, President and CEO
"We got off to a good start in fiscal year 2011/12. Revenue and earnings have exceeded our targeted figures. The general economic climate proved to be very stable in many areas. Through our broad diversification, we were able to largely compensate for the cyclical downturn in the Semiconductor Manufacturing Technology group. This underscores the strength of our portfolio."
Keywords: Carl Zeiss Financial Report Fiscal Year 2011/2012 Industrial Metrology Medical Technology Michael Kaschke Microscopy Revenues Sales Report Vision Care
![]()
Imaging & Microscopy Issue 4 , 2012 as free epaper or pdf download
Reader comments (0)